These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 9183392)

  • 1. [Influence of anti-arrhythmia agents on heart rate variability].
    Brembilla-Perrot B; Alsagheer S; Jacquemin L; Beurrier D; Retournay G; Grentzinger A
    Ann Cardiol Angeiol (Paris); 1997 Mar; 46(3):129-34. PubMed ID: 9183392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prediction of long-term efficacy of amiodarone for refractory ventricular tachycardia: clinical significance of electrophysiologic study and Holter monitoring].
    Tsuchiya M; Kasanuki H; Ohnishi S; Hosoda S
    J Cardiol; 1996 Nov; 28(5):267-76. PubMed ID: 8953400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heart rate variability in patients suffering from structural heart disease and decreased AV-nodal conduction capacity. Insights into the formation of heart rate variability.
    Schwab JO; Eichner G; Schmitt H; Schrickel J; Yang A; Balta O; Lüderitz B; Lewalter T
    Z Kardiol; 2004 Mar; 93(3):229-33. PubMed ID: 15024591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Combination of celiprolol and amiodarone in the treatment of recurrent ventricular tachycardia].
    Tonet J; Hidden F; Naditch L; Coutte R; Himbert C; Frank R
    Ann Cardiol Angeiol (Paris); 1996 Jan; 45(1):18-23. PubMed ID: 8815771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
    Castelli G; Ciaccheri M; Cecchi F; Troiani V; Nannini M; Marconi P; Olivotto J; Montereggi A; Dolara A
    G Ital Cardiol; 1999 May; 29(5):514-23. PubMed ID: 10367218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Quinidine and high-amplification ECG].
    Brembilla-Perrot B; Beurrier D; Jacquemin L; Malak S; Danchin N
    Ann Cardiol Angeiol (Paris); 1997 Jan; 46(1):15-20. PubMed ID: 9092373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of pacing protocol and beta-blockers on the results of serial drug testing in sustained ventricular tachycardia].
    Lukl J; Heinc P; Cíhalík C; Fiala M
    Cor Vasa; 1993; 35(3):116-20. PubMed ID: 8102329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The amiodarone-beta blockers combination could represent an alternative treatment in patients at risk for sudden death in which a benefit from implantable defibrillators has not been clearly demonstrated].
    Alboni P
    Ital Heart J Suppl; 2002 Mar; 3(3):337-43. PubMed ID: 12040849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationships between heart rate variability and antiarrhythmic effects of hydroquinidine.
    Brembilla-Perrot B; Jacquemin L; Beurrier D
    Cardiovasc Drugs Ther; 1997 Jul; 11(3):493-8. PubMed ID: 9310279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective clinical evaluation and follow-up of a cohort of consecutive VT/VF patients, using a staged-care protocol, including coronary arteriography, programmed electrical stimulation and cardiac surgery.
    Naccarella F; Rolli A; Carboni A; Finardi A; Aurier E; Favaro L; Contini S; Gherli T; Caponi D; Maranga SS; Lepera G; Bartoletti A
    G Ital Cardiol; 1999 Oct; 29(10):1142-56. PubMed ID: 10546124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Description of time- and frequency- domain-based measures of heart rate variability in individuals taking antiarrhythmics, beta blockers, calcium channel blockers, and/or antihypertensive drugs after sudden cardiac arrest.
    Cowan MJ; Pike K; Burr RL; Cain KC; Narayanan SB
    J Electrocardiol; 1993; 26 Suppl():1-13. PubMed ID: 7910623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Na+ channel blockers vs class III antiarrhythmic drugs in treating sustained ventricular tachycardia: reversing and preventing as different electrophysiological mechanisms.
    Masotti CS; Pierangeli A
    Panminerva Med; 1999 Dec; 41(4):295-306. PubMed ID: 10705709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of determination of QT dispersal intervals in anti-arrhythmia therapy].
    Konecná P; Dvorák R; Semrád B
    Vnitr Lek; 1999 Aug; 45(8):453-6. PubMed ID: 11045143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic effects of amiodarone and metoprolol on chronic heart failure complicated by ventricular arrhythmia].
    Lü HS; He BB; Huang GH
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jun; 29(6):1240-2. PubMed ID: 19726373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart rate variability in heart failure.
    Musialik-Łydka A; Sredniawa B; Pasyk S
    Kardiol Pol; 2003 Jan; 58(1):10-6. PubMed ID: 14502297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amiodarone or procainamide for the termination of sustained stable ventricular tachycardia: an historical multicenter comparison.
    Marill KA; deSouza IS; Nishijima DK; Senecal EL; Setnik GS; Stair TO; Ruskin JN; Ellinor PT
    Acad Emerg Med; 2010 Mar; 17(3):297-306. PubMed ID: 20370763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of electrophysiologic effects of quinidine and amiodarone in sustained ventricular tachyarrhythmias associated with coronary artery disease.
    Pastor A; Almendral JM; Arenal A; Lorca MT; Delcán JL
    Am J Cardiol; 1993 Dec; 72(18):1389-94. PubMed ID: 8256732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of sotalol on heart rate variability in patients with symptomatic, complex ventricular arrhythmias].
    Klingenheben T; Hohnloser SH
    Z Kardiol; 1994 Apr; 83(4):293-8. PubMed ID: 8023542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of recurrent ventricular arrhythmia or death in 300 consecutive patients with ischemic heart disease who experienced aborted sudden death: data from the Leiden out-of-hospital cardiac arrest study.
    Kiès P; Boersma E; Bax JJ; van der Burg AE; Bootsma M; van Erven L; van der Wall EE; Schalij MJ
    J Cardiovasc Electrophysiol; 2005 Oct; 16(10):1049-56. PubMed ID: 16191114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excessive increase in QT interval and dispersion of repolarization predict recurrent ventricular tachyarrhythmia after amiodarone.
    Aiba T; Shimizu W; Inagaki M; Satomi K; Taguchi A; Kurita T; Suyama K; Aihara N; Sunagawa K; Kamakura S
    Pacing Clin Electrophysiol; 2004 Jul; 27(7):901-9. PubMed ID: 15271008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.